Superpulse thulium fiber versus holmium:YAG laser for breaking kidney and upper ureter stones during ureteroscopy
Official title: Comparison of Super Pulse Fiber Thulium Laser and Holmium Laser Lithotripsy Under Ureteroscopy
Run by Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine · NCT06667557 · Data updated 2026-11-12
This trial tests whether the superpulse thulium fiber laser works better than the holmium:YAG laser for adults (18–70) having ureteroscopy to break 6–20 mm kidney or upper ureter stones.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 136 (estimated) |
| Sponsor | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | January 20, 2025 |
| Main results expected | October 20, 2027 |
| Study ends | October 20, 2028 |
| Registry record updated | January 21, 2026 |
| Trial ID | NCT06667557 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–70 with kidney or upper ureter stones measuring 6–20 mm who are scheduled for flexible ureteroscopy under general anesthesia.
✕Probably not a fit
Patients with a single kidney, untreated urinary infection, major urinary tract anatomic abnormalities, prior urinary diversion or transplant, or severe comorbid conditions are excluded and unlikely to benefit from joining this trial.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This prospective, randomized controlled trial will enroll 136 adults (18–70) with CT-confirmed kidney or upper ureter stones 6–20 mm and randomize them 1:1 to flexible ureteroscopy (FURS) using either superpulse thulium fiber laser (sTFL) or holmium:YAG laser (Ho:YAG). Procedures are performed under general anesthesia and the primary outcome is stone-free rate at 3 months, defined as residual fragments <2 mm on CT. Secondary outcomes include operation time, intra- and postoperative complications graded by Clavien–Dindo, surgeon visual experience, and stone recurrence at 6 months. Participants will be monitored closely for adverse events throughout the study period.
Why it matters
Potential benefit: If successful, sTFL could increase stone-free rates and shorten operating time, reducing the need for repeat procedures and lowering complication rates.
How similar studies have gone: Early clinical series and smaller randomized trials have shown promising improvements in dusting efficiency and operative time with sTFL, but large multicenter randomized evidence is still limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥18 years old * Diagnosis of kidney stones and/or upper ureteral stones with stone diameter ≥6mm and ≤20mm * Plan to undergo fURS lithotripsy * General anesthesia to complete the operation * The latest urine culture before surgery is negative * Signed and dated informed consent indicating that the patient or his or her legal representative has been fully informed about the study and has consented to participate Exclusion Criteria: * Isolated kidney * Previous history of kidney transplantation or urinary diversion surgery * Congenital malformations of urinary system * Abnormal coagulation mechanism due to blood system diseases, liver diseases, etc. * Severe heart or lung disease, malignancy and immune deficiency status * Neurogenic bladder * Failure to provide informed consent * Have an untreated urinary tract infection * The presence of known anatomic abnormalities (such as ureteral stenosis), urothelial tumors, or stones that can be removed directly without the use of laser lithotripsy * Pregnant women * In cases where the stone cannot be reached with a bendable negative pressure suction sheath, or in cases where the stone cannot be reached with a conventional sheath or the pyeloureteral junction * Surgical completion under epidural anesthesia or lumbar anesthesia * Recurrent stones due to genetic metabolic diseases
Where it's running
-
Shanghai General Hospital
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Principal investigator: Yi Shao — Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- Study coordinator: Ruixuan Zhu
- Email: luluzhu2023@qq.com
- Phone: +86 13780820139
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Suction vs Conventional Ureteral Access Sheaths in Kidney Stone Surgery
This study tests whether using a suction ureteral access sheath during RIRS helps adults clear stones more often and potentially reduces operative time and infections compared with a conventional sheath.
-
Audio consent with human voice or AI-voice added to written consent for ureteroscopy
This study tests if listening to an audio version of the consent form, read by a real urologist or by an AI-cloned voice, helps adults in Turkey understand their ureteroscopy or RIRS consent better than the written form alone.
-
Nephrostomy Tract Infiltration to Ease Pain After Percutaneous Nephrolithotomy
This trial tests whether injecting local anesthetic into the nephrostomy tract after PCNL helps reduce postoperative pain for adults undergoing the procedure.
-
Gentamicin Irrigation and Suction Ureteral Access in Kidney Stone Surgery
This trial tests whether using gentamicin-containing irrigation fluid and a suction-enabled ureteral access sheath during retrograde intrarenal surgery (RIRS) can lower fever, SIRS, and sepsis after kidney stone treatment.
-
Using a flexible suction sheath with flexible ureteroscopy for lower-pole kidney stones
This trial will test whether adding a flexible, navigable suction sheath to flexible ureteroscopy helps adults with lower-pole kidney stones become stone-free more often and avoid repeat procedures.
-
Investigating oxalate production in patients with calcium oxalate kidney stones
This study is testing if people with calcium oxalate kidney stones produce more oxalate in their bodies than healthy individuals by following a special diet and taking certain supplements.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.